Cytokine imbalance in acute coronary syndrome

Area of Science:

• Cardiovascular Science
• Inflammation Research
• Thrombosis Studies

Background:

• Coronary heart disease (CHD) mortality is largely due to atherosclerotic plaque rupture and thrombosis.
• Inflammation is a key driver of plaque destabilization and vulnerability.
• Inflammation extends beyond the affected site, impacting the entire vascular system.

Purpose of the Study:

• To explore the role of inflammation in atherosclerotic plaque destabilization.
• To investigate the contribution of platelets to plaque inflammation.
• To identify new diagnostic and therapeutic strategies targeting inflammation in CHD.

Main Methods:

• Review of existing literature on inflammation, atherosclerosis, and thrombosis.
• Analysis of systemic inflammatory, thrombotic, and hemodynamic factors.
• Examination of the role of platelets and cytokines in plaque progression.

Main Results:

• Inflammation is a critical, widespread factor in plaque vulnerability and CHD outcomes.
• Platelets significantly contribute to plaque inflammation beyond their role in thrombosis.
• Emerging evidence points to unbalanced cytokine-mediated inflammation as a key pathological mechanism.

Conclusions:

• Targeting inflammation, especially cytokine-mediated pathways, presents significant diagnostic and therapeutic opportunities for CHD.
• Enhancing intrinsic anti-inflammatory mechanisms is a promising future research direction.
• A comprehensive understanding of systemic factors is crucial for managing CHD.